Newark, NJ ― BioNJ, the trade association for New Jersey's life sciences industry, announced that Rebecca Perkins joined the organization as Vice President, Government Affairs. Rebecca brings with her over 20 years of experience as a public policy and communications strategist.
Rebecca served as President and CEO of The Perkins Partnership, a public policy consulting firm focused on advocacy, stakeholder engagement, strategic communications and nonprofit organizations, with special expertise in healthcare and life sciences.
Rebecca served as President and CEO of The Perkins Partnership, a public policy consulting firm focused on advocacy, stakeholder engagement, strategic communications and nonprofit organizations, with special expertise in healthcare and life sciences.
Prior to that, Rebecca served as Senior Vice President at the HealthCare Institute of New Jersey, where she led communications, legislative and philanthropic initiatives focused on healthcare; Special Assistant to the President of the University of Medicine & Dentistry for External Affairs, where she promoted private/academic research relationships and represented the University to the life sciences community; and Executive Vice President and Chief Operating Officer at Prosperity New Jersey in the administration of New Jersey Governor James McGreevey, where she led policy and mission initiatives.
“We are delighted to have someone with Rebecca's experience and talents in this position of advancing BioNJ's advocacy efforts at the State and federal levels as BioNJ champions policy initiatives to help our Member companies help Patients,” said BioNJ President and CEO Debbie Hart.
Rebecca can be reached at RPerkins@BioNJ.org or at 609-890-3185.
About BioNJ
BioNJ, The Gateway to Health, is a powerful network of 400 Members representing research-based life sciences companies and stakeholders dedicated to propelling a vibrant ecosystem where Science is Supported, Companies are Created, Drugs are Developed and Patients are Paramount.
Because Patients Can’t WaitSM, BioNJ supports its Members in the discovery, development and commercialization of therapies and cures that save and improve lives and lessen the burden of illness and disease to society by driving capital formation, fostering entrepreneurship, advocating for public policies that advance medical innovation, providing access to talent and education and offering a cost-saving array of critical commercial resources.
“We are delighted to have someone with Rebecca's experience and talents in this position of advancing BioNJ's advocacy efforts at the State and federal levels as BioNJ champions policy initiatives to help our Member companies help Patients,” said BioNJ President and CEO Debbie Hart.
Rebecca can be reached at RPerkins@BioNJ.org or at 609-890-3185.
About BioNJ
BioNJ, The Gateway to Health, is a powerful network of 400 Members representing research-based life sciences companies and stakeholders dedicated to propelling a vibrant ecosystem where Science is Supported, Companies are Created, Drugs are Developed and Patients are Paramount.
Because Patients Can’t WaitSM, BioNJ supports its Members in the discovery, development and commercialization of therapies and cures that save and improve lives and lessen the burden of illness and disease to society by driving capital formation, fostering entrepreneurship, advocating for public policies that advance medical innovation, providing access to talent and education and offering a cost-saving array of critical commercial resources.
